Neurocrine Biosciences Total Assets 2010-2025 | NBIX

Neurocrine Biosciences total assets from 2010 to 2025. Total assets can be defined as the sum of all assets on a company's balance sheet.
  • Neurocrine Biosciences total assets for the quarter ending March 31, 2025 were $3.688B, a 6.2% increase year-over-year.
  • Neurocrine Biosciences total assets for 2024 were $3.719B, a 14.37% increase from 2023.
  • Neurocrine Biosciences total assets for 2023 were $3.251B, a 37.27% increase from 2022.
  • Neurocrine Biosciences total assets for 2022 were $2.369B, a 14.29% increase from 2021.
Neurocrine Biosciences Annual Total Assets
(Millions of US $)
2024 $3,719
2023 $3,251
2022 $2,369
2021 $2,073
2020 $1,735
2019 $1,306
2018 $993
2017 $818
2016 $365
2015 $475
2014 $243
2013 $155
2012 $196
2011 $138
2010 $144
2009 $71
Neurocrine Biosciences Quarterly Total Assets
(Millions of US $)
2025-03-31 $3,688
2024-12-31 $3,719
2024-09-30 $3,535
2024-06-30 $3,305
2024-03-31 $3,472
2023-12-31 $3,251
2023-09-30 $2,848
2023-06-30 $2,613
2023-03-31 $2,360
2022-12-31 $2,369
2022-09-30 $2,143
2022-06-30 $2,006
2022-03-31 $2,145
2021-12-31 $2,073
2021-09-30 $2,017
2021-06-30 $1,956
2021-03-31 $1,846
2020-12-31 $1,735
2020-09-30 $1,503
2020-06-30 $1,516
2020-03-31 $1,362
2019-12-31 $1,306
2019-09-30 $1,180
2019-06-30 $1,067
2019-03-31 $958
2018-12-31 $993
2018-09-30 $934
2018-06-30 $841
2018-03-31 $806
2017-12-31 $818
2017-09-30 $772
2017-06-30 $754
2017-03-31 $289
2016-12-31 $365
2016-09-30 $399
2016-06-30 $430
2016-03-31 $459
2015-12-31 $475
2015-09-30 $492
2015-06-30 $511
2015-03-31 $528
2014-12-31 $243
2014-09-30 $258
2014-06-30 $270
2014-03-31 $279
2013-12-31 $155
2013-09-30 $166
2013-06-30 $175
2013-03-31 $184
2012-12-31 $196
2012-09-30 $193
2012-06-30 $202
2012-03-31 $210
2011-12-31 $138
2011-09-30 $149
2011-06-30 $127
2011-03-31 $134
2010-12-31 $144
2010-09-30 $150
2010-06-30 $155
2010-03-31 $80
2009-12-31 $71
2009-09-30 $76
2009-06-30 $87
2009-03-31 $101
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $13.138B $2.355B
Neurocrine Biosciences is a neuroscience-based company focused on the discovery and development of novel therapeutics for neuropsychiatric, neuroinflammatory and neurodegenerative diseases and disorders. The company's neuroscience, endocrine and immunology disciplines provide a unique biological understanding of the molecular interaction between central nervous, immune and endocrine systems for the development of therapeutic interventions for anxiety, depression, insomnia, stroke, malignant brain tumors, multiple sclerosis, obesity and diabetes.
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) Japan $75.891B 28.47
Zoetis (ZTS) United States $67.311B 25.11
Takeda Pharmaceutical (TAK) Japan $46.297B 9.21
Daiichi Sankyo, - (DSNKY) Japan $45.521B 23.33
BeOne Medicines - (ONC) Cayman Islands $32.397B 0.00
Sandoz Group AG (SDZNY) Switzerland $25.766B 0.00
Summit Therapeutics (SMMT) United States $19.710B 0.00
Merck (MKKGY) Germany $16.653B 12.20
Shionogi (SGIOY) Japan $14.019B 14.05
United Therapeutics (UTHR) United States $13.437B 11.89
Orion OYJ (ORINY) Finland $11.666B 28.12
IPSEN (IPSEY) France $10.323B 0.00
Stevanato Group S.p.A (STVN) Italy $7.420B 45.37
Corcept Therapeutics (CORT) United States $7.326B 59.55
Madrigal Pharmaceuticals (MDGL) United States $6.959B 0.00
Ionis Pharmaceuticals (IONS) United States $6.677B 0.00
Grifols, S.A (GRFS) Spain $6.642B 0.00
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $6.153B 0.00
Ono Pharmaceutical (OPHLF) Japan $5.214B 15.86
Soleno Therapeutics (SLNO) United States $4.335B 0.00
Procaps Group, S.A (PROCF) Luxembourg $3.225B 0.00
Hypermarcas (HYPMY) Brazil $3.034B 19.96
Crinetics Pharmaceuticals (CRNX) United States $2.853B 0.00
NewAmsterdam Pharma (NAMS) Netherlands $2.574B 0.00
Catalyst Pharmaceuticals (CPRX) United States $2.549B 8.93
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.495B 13.49
Centessa Pharmaceuticals (CNTA) United Kingdom $2.160B 0.00
Ocular Therapeutix (OCUL) United States $1.840B 0.00
BioCryst Pharmaceuticals (BCRX) United States $1.810B 0.00
ARS Pharmaceuticals (SPRY) United States $1.728B 0.00
Endo (NDOI) United States $1.603B 0.00
Harrow (HROW) United States $1.325B 0.00
Evotec AG (EVO) Germany $1.321B 0.00
Guardian Pharmacy Services (GRDN) United States $1.287B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.200B 24.00
Avadel Pharmaceuticals (AVDL) Ireland $1.086B 0.00
Ardelyx (ARDX) United States $1.059B 0.00
Enliven Therapeutics (ELVN) United States $1.058B 0.00
Dyne Therapeutics (DYN) United States $1.047B 0.00
Collegium Pharmaceutical (COLL) United States $1.017B 5.48
Akebia Therapeutics (AKBA) United States $1.011B 0.00
Verve Therapeutics (VERV) United States $0.988B 0.00
ProKidney (PROK) United States $0.893B 0.00
Cronos Group (CRON) Canada $0.825B 0.00
Xeris Biopharma Holdings (XERS) United States $0.801B 0.00
KalVista Pharmaceuticals (KALV) United States $0.790B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.702B 0.00
Xencor (XNCR) United States $0.655B 0.00
Relay Therapeutics (RLAY) United States $0.636B 0.00
Zevra Therapeutics (ZVRA) United States $0.633B 0.00
Organogenesis (ORGO) United States $0.611B 0.00
Elite Pharmaceuticals (ELTP) United States $0.589B 0.00
USANA Health Sciences (USNA) United States $0.587B 11.81
Theravance Biopharma (TBPH) United States $0.562B 0.00
Bioventus (BVS) United States $0.529B 13.42
Oruka Therapeutics (ORKA) United States $0.526B 0.00
Siga Technologies (SIGA) United States $0.489B 10.22
Tourmaline Bio (TRML) United States $0.484B 0.00
Savara (SVRA) United States $0.417B 0.00
Aquestive Therapeutics (AQST) United States $0.394B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.359B 9.69
Altimmune (ALT) United States $0.341B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.329B 0.00
Aldeyra Therapeutics (ALDX) United States $0.321B 0.00
AleAnna (ANNA) United States $0.307B 0.00
Nektar Therapeutics (NKTR) United States $0.304B 0.00
Heron Therapeutics (HRTX) United States $0.290B 0.00
Nature's Sunshine Products (NATR) United States $0.276B 25.37
OmniAb (OABI) United States $0.252B 0.00
Esperion Therapeutics (ESPR) United States $0.242B 0.00
Nanobiotix S.A (NBTX) France $0.240B 0.00
MediWound (MDWD) Israel $0.221B 0.00
Larimar Therapeutics (LRMR) United States $0.216B 0.00
4D Molecular Therapeutics (FDMT) United States $0.208B 0.00
China SXT Pharmaceuticals (SXTC) China $0.204B 0.00
Galectin Therapeutics (GALT) United States $0.181B 0.00
Profound Medical (PROF) Canada $0.176B 0.00
Aclaris Therapeutics (ACRS) United States $0.175B 0.00
Journey Medical (DERM) United States $0.169B 0.00
Avita Medical (RCEL) United States $0.154B 0.00
Lyell Immunopharma (LYEL) United States $0.152B 0.00
Liminatus Pharma (LIMN) United States $0.150B 0.00
Inhibikase Therapeutics (IKT) United States $0.143B 0.00
Korro Bio (KRRO) United States $0.133B 0.00
Lexeo Therapeutics (LXEO) United States $0.129B 0.00
Protara Therapeutics (TARA) United States $0.128B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.126B 0.00
Cassava Sciences (SAVA) United States $0.125B 0.00
Cardiol Therapeutics (CRDL) Canada $0.116B 0.00
Innate Pharma SA (IPHYF) France $0.110B 0.00
Champions Oncology (CSBR) United States $0.108B 17.83
Corbus Pharmaceuticals Holdings (CRBP) United States $0.106B 0.00
Nutriband (NTRB) United States $0.097B 0.00
VAXART, INC (VXRT) United States $0.093B 0.00
Vivani Medical (VANI) United States $0.092B 0.00
Achieve Life Sciences (ACHV) Canada $0.092B 0.00
Fractyl Health (GUTS) United States $0.091B 0.00
Metagenomi (MGX) United States $0.087B 0.00
Arch Biopartners (ACHFF) Canada $0.085B 0.00
ESSA Pharma (EPIX) Canada $0.083B 0.00
Dominari Holdings (DOMH) United States $0.077B 0.00
Rafael Holdings (RFL) United States $0.076B 0.00
Context Therapeutics (CNTX) United States $0.074B 0.00
Surrozen (SRZN) United States $0.074B 0.00
Wellgistics Health (WGRX) United States $0.074B 0.00
Inotiv (NOTV) United States $0.072B 0.00
Pyxis Oncology (PYXS) United States $0.070B 0.00
Avalo Therapeutics (AVTX) United States $0.070B 0.00
Assertio Holdings (ASRT) United States $0.069B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.067B 0.00
PMV Pharmaceuticals (PMVP) United States $0.066B 0.00
Telomir Pharmaceuticals (TELO) United States $0.063B 0.00
Klotho Neurosciences (KLTO) United States $0.062B 0.00
Allergy Therapeutics (AGYTF) United Kingdom $0.059B 0.00
Unicycive Therapeutics (UNCY) United States $0.057B 0.00
Jupiter Neurosciences (JUNS) United States $0.056B 0.00
ElectroCore (ECOR) United States $0.052B 0.00
NRx Pharmaceuticals (NRXP) United States $0.052B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.051B 37.78
Century Therapeutics (IPSC) United States $0.050B 0.00
Gain Therapeutics (GANX) United States $0.049B 0.00
Prelude Therapeutics (PRLD) United States $0.048B 0.00
Acrivon Therapeutics (ACRV) United States $0.044B 0.00
Mural Oncology (MURA) Ireland $0.042B 0.00
PolyPid (PYPD) Israel $0.038B 0.00
Karyopharm Therapeutics (KPTI) United States $0.034B 0.00
Iterum Therapeutics (ITRM) Ireland $0.033B 0.00
Vivos Therapeutics (VVOS) United States $0.032B 0.00
FibroGen (FGEN) United States $0.031B 0.00
Scienture Holdings (SCNX) United States $0.029B 0.00
Enlivex Therapeutics (ENLV) Israel $0.028B 0.00
SCYNEXIS (SCYX) United States $0.028B 0.00
Plus Therapeutics (PSTV) United States $0.026B 0.00
Incannex Healthcare (IXHL) Australia $0.025B 0.00
Tempest Therapeutics (TPST) United States $0.023B 0.00
Natural Alternatives (NAII) United States $0.021B 0.00
Relmada Therapeutics (RLMD) United States $0.021B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.020B 0.00
BioLineRx (BLRX) Israel $0.019B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.018B 0.00
Lipocine (LPCN) United States $0.017B 0.00
DURECT (DRRX) United States $0.017B 0.00
VYNE Therapeutics (VYNE) United States $0.017B 0.00
ProPhase Labs (PRPH) United States $0.016B 0.00
Carisma Therapeutics (CARM) United States $0.016B 0.00
Mannatech (MTEX) United States $0.016B 0.00
Citius Pharmaceuticals (CTXR) United States $0.016B 0.00
CASI Pharmaceuticals (CASI) China $0.015B 0.00
BioVie (BIVI) United States $0.015B 0.00
Ernexa Therapeutics (ERNA) United States $0.015B 0.00
Minerva Neurosciences (NERV) United States $0.014B 2.41
Cosmos Health (COSM) United States $0.014B 0.00
TherapeuticsMD (TXMD) United States $0.013B 0.00
Phio Pharmaceuticals (PHIO) United States $0.012B 0.00
Ainos (AIMD) United States $0.011B 0.00
Lyra Therapeutics (LYRA) United States $0.011B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.010B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.009B 0.00
Biomerica (BMRA) United States $0.009B 0.00
Traws Pharma (TRAW) United States $0.009B 0.00
Aptorum Group (APM) United Kingdom $0.009B 0.00
Mangoceuticals (MGRX) United States $0.008B 0.00
Addex Therapeutics (ADXN) Switzerland $0.008B 0.00
Talphera (TLPH) United States $0.008B 0.00
TransCode Therapeutics (RNAZ) United States $0.008B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.008B 0.00
Nuvilex (PMCB) United States $0.007B 0.00
Indaptus Therapeutics (INDP) United States $0.006B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.006B 0.00
Xenetic Biosciences (XBIO) United States $0.006B 0.00
InMed Pharmaceuticals (INM) Canada $0.005B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.005B 0.00
Redhill Biopharma (RDHL) Israel $0.005B 0.00
Qualigen Therapeutics (QLGN) United States $0.005B 0.00
Alaunos Therapeutics (TCRT) United States $0.005B 0.00
Clearmind Medicine (CMND) Canada $0.005B 0.00
SciSparc (SPRC) Israel $0.004B 0.00
XORTX Therapeutics (XRTX) Canada $0.004B 0.00
SHINECO (SISI) China $0.003B 0.00
CERo Therapeutics Holdings (CERO) United States $0.003B 0.00
PainReform (PRFX) Israel $0.003B 0.00
Heatwurx (PCSA) United States $0.003B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.003B 0.00
Aditxt (ADTX) United States $0.003B 0.00
Jaguar Animal Health (JAGX) United States $0.002B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.002B 0.00
Conduit Pharmaceuticals (CDT) United States $0.002B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.002B 0.00
TNF Pharmaceuticals (TNFA) United States $0.002B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.002B 0.00
Universe Pharmaceuticals INC (UPC) China $0.000B 0.00
Indivior (INDV) United States $0.000B 9.46
4D Pharma (LBPS) United Kingdom $0.000B 0.00
MEI Pharma (MEIP) United States $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Silence Therapeutics (SLN) United Kingdom $0.000B 0.00